Forskning ved Københavns Universitet - Københavns Universitet

Forside

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.

Publikation: Bidrag til tidsskriftReviewForskning

Standard

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. / Andreasen, N C; Carson, R; Diksic, M; Evans, A; Farde, L; Gjedde, A; Hakim, A; Lal, S; Nair, N; Sedvall, G.

I: Schizophrenia Bulletin, Bind 14, Nr. 3, 1988, s. 471-84.

Publikation: Bidrag til tidsskriftReviewForskning

Harvard

Andreasen, NC, Carson, R, Diksic, M, Evans, A, Farde, L, Gjedde, A, Hakim, A, Lal, S, Nair, N & Sedvall, G 1988, 'Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.', Schizophrenia Bulletin, bind 14, nr. 3, s. 471-84.

APA

Andreasen, N. C., Carson, R., Diksic, M., Evans, A., Farde, L., Gjedde, A., ... Sedvall, G. (1988). Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin, 14(3), 471-84.

Vancouver

Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A o.a. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin. 1988;14(3):471-84.

Author

Andreasen, N C ; Carson, R ; Diksic, M ; Evans, A ; Farde, L ; Gjedde, A ; Hakim, A ; Lal, S ; Nair, N ; Sedvall, G. / Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. I: Schizophrenia Bulletin. 1988 ; Bind 14, Nr. 3. s. 471-84.

Bibtex

@article{40459280b31511debc73000ea68e967b,
title = "Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.",
abstract = "Recently, two research groups published numbers for D2 receptor sites in the neostriatum of drug-naive schizophrenic patients, obtained in vivo by positron emission tomography (PET). One study appeared to confirm the increase of D2 receptor numbers, while the other study did not. A workshop was convened in Montreal to examine the reasons for the discrepancy between the results obtained by the two groups. The workshop considered patient populations, PET instrumentation and scanning methods, pharmacology, and modeling. The workshop identified differences between the approaches of the two groups that could contribute to the divergent results, including age and chronicity of the patient samples, brain region selected for study, metabolism of the different radioligands in blood and brain, reversibility of binding, PET instrumentation, and complexity of data analysis. The workshop concluded that these initial efforts had made considerable progress in establishing the role of PET in the understanding of the biochemical processes underlying mental illness. In particular, the unique ability to quantify regional neuroreceptor density at different stages in the evolution of the disease has been implemented. At the same time, the work so far and this conference served to identify the main sources contributing to the different findings from the two centers. This information will be important in designing the next phase of the research which will build upon and reconcile these apparent discrepancies.",
author = "Andreasen, {N C} and R Carson and M Diksic and A Evans and L Farde and A Gjedde and A Hakim and S Lal and N Nair and G Sedvall",
year = "1988",
language = "English",
volume = "14",
pages = "471--84",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "3",

}

RIS

TY - JOUR

T1 - Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.

AU - Andreasen, N C

AU - Carson, R

AU - Diksic, M

AU - Evans, A

AU - Farde, L

AU - Gjedde, A

AU - Hakim, A

AU - Lal, S

AU - Nair, N

AU - Sedvall, G

PY - 1988

Y1 - 1988

N2 - Recently, two research groups published numbers for D2 receptor sites in the neostriatum of drug-naive schizophrenic patients, obtained in vivo by positron emission tomography (PET). One study appeared to confirm the increase of D2 receptor numbers, while the other study did not. A workshop was convened in Montreal to examine the reasons for the discrepancy between the results obtained by the two groups. The workshop considered patient populations, PET instrumentation and scanning methods, pharmacology, and modeling. The workshop identified differences between the approaches of the two groups that could contribute to the divergent results, including age and chronicity of the patient samples, brain region selected for study, metabolism of the different radioligands in blood and brain, reversibility of binding, PET instrumentation, and complexity of data analysis. The workshop concluded that these initial efforts had made considerable progress in establishing the role of PET in the understanding of the biochemical processes underlying mental illness. In particular, the unique ability to quantify regional neuroreceptor density at different stages in the evolution of the disease has been implemented. At the same time, the work so far and this conference served to identify the main sources contributing to the different findings from the two centers. This information will be important in designing the next phase of the research which will build upon and reconcile these apparent discrepancies.

AB - Recently, two research groups published numbers for D2 receptor sites in the neostriatum of drug-naive schizophrenic patients, obtained in vivo by positron emission tomography (PET). One study appeared to confirm the increase of D2 receptor numbers, while the other study did not. A workshop was convened in Montreal to examine the reasons for the discrepancy between the results obtained by the two groups. The workshop considered patient populations, PET instrumentation and scanning methods, pharmacology, and modeling. The workshop identified differences between the approaches of the two groups that could contribute to the divergent results, including age and chronicity of the patient samples, brain region selected for study, metabolism of the different radioligands in blood and brain, reversibility of binding, PET instrumentation, and complexity of data analysis. The workshop concluded that these initial efforts had made considerable progress in establishing the role of PET in the understanding of the biochemical processes underlying mental illness. In particular, the unique ability to quantify regional neuroreceptor density at different stages in the evolution of the disease has been implemented. At the same time, the work so far and this conference served to identify the main sources contributing to the different findings from the two centers. This information will be important in designing the next phase of the research which will build upon and reconcile these apparent discrepancies.

M3 - Review

C2 - 2975043

VL - 14

SP - 471

EP - 484

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 3

ER -

ID: 14946716